This document provides an overview and summary of DelveInsight's Chronic Kidney Disease (CKD) Market Insight, Epidemiology and Market Forecast report. The report analyzes the CKD market in 7 major markets from 2017-2030, including the US, EU5, and Japan. It covers epidemiology segmentation, emerging therapies, market drivers and barriers, KOL insights, and pricing and reimbursement. The report provides a comprehensive analysis of the CKD treatment landscape, pipeline drugs, market size by therapies, and historical and forecasted epidemiological data.

1. Chronic Kidney Disease (CKD)
Market Insight, Epidemiology and Market Forecast - 2030

2. Private and Confidential
Introduction to DelveInsight
To help organizations make important business
decisions through the use and analysis of
actionable market intelligence. It is our mission to
provide the most effective results and services
coupled with acute client care to create a long-
lasting relationship with our clients.
Mission
To become the most trusted marketing research &
business consulting firm worldwide.
To be a renowned and premier data driven solution
providers among Pharma & Biotech companies.
Vision
Actionable
Intelligence
Shaping & Influencing
the Strategic Thinking
Accurate market
assessment of competitors,
products & technology
provides DelveInsight
insightful valuation of
industry evolution. Understanding
Industry
Evolution
Industry
Experience
In-depth knowledge of
Healthcare Industry with
focus on Pharmaceutical
and Biotechnological
Domain.
Discovering liabilities for a
more robust intelligence
output, uncovering possible
reasons for strategic failure,
and work to avoid them.
Blind spot
Analysis
Dedicated
Monitoring
Focused on current players
tracking, as well as on
monitoring new entrants for
forecasting their impact on
the market. Emphasis is on
checking for any disruptive
substitute in the market.

3. Lorem Ipsum is simply dummy text of the printing and typesetting industry.
Lorem Ipsum has been the industry's standard dummy text ever since the
1500s.
KPI Dashboard
Your great subtitle in this line
Lorem ipsum dolor sit
amet, consectetur
Drink Coffee
Lorem ipsum dolor sit
amet, consectetur
Mobile Data
Lorem ipsum dolor sit
amet, consectetur
Love
Overview of pathophysiology, various
diagnostic approaches and treatment
algorithm including detailed chapters for
marketed products and emerging therapies
Detailed historical and forecasted
market covering the United States,
EU5, and Japan from 2017 to 2030
Pipeline analysis across different stages of
development (Phase III and Phase II),
different emerging trends and comparative
analysis of pipeline products with detailed
clinical profiles, key cross -competition,
launch date along with product development
activities.
Detailed Market size by therapies,
covering the United States, EU5
(Germany, France, Italy, Spain, and
United Kingdom), and Japan from
2017 to 2030
Historical as well as forecasted epidemiology
in 7MM covering the United States, EU5
(Germany, France, Italy, Spain, and United
Kingdom), and Japan from 2017 to 2030
Research
Analysis
Market
Analysis
Pipeline
Valuation
Market Size by
Therapies
Epidem
Forecast
Chronic Kidney Disease (CKD)

4. A detailed review of Chronic Kidney
Disease (CKD) market; historical and
forecasted is included in the report,
covering drug outreach in the 7MM
Comprehensive insight has been provided
into the Chronic Kidney Disease (CKD)
epidemiology and treatment in the 7MM
The report covers the descriptive overview
of Chronic Kidney Disease (CKD), explaining
its causes, signs and symptoms,
pathophysiology and currently available
therapies
Additionally, an all-inclusive account of both
the current and emerging therapies for
Chronic Kidney Disease (CKD) are provided,
along with the assessment of new therapies,
which will have an impact on the current
treatment landscape
4
The report provides an edge while developing
business strategies, by understanding trends
shaping and driving the global Chronic Kidney
Disease (CKD) market
Scope Of Report

5. D
D
Chronic Kidney Disease (CKD) - Introduction
• Chronic kidney disease (CKD) is a syndrome where there are persistent
alterations in kidney structure, function, or both with implications on the health of
the individual. Examples of structural abnormalities include cysts, tumors,
malformations and atrophy, which are evident on imaging. By contrast, kidney
dysfunction can manifest as hypertension, edema, changes in output or quality of
urine and growth delay in children. These changes are most often recognized by
increased serum levels of creatinine, cystatin C, or blood urea nitrogen.
Moreover, the most common pathological manifestation of CKD, regardless of
the initiating insult or disease, is some form of renal fibrosis.
• The Kidney Disease Improving Global Outcomes (KDIGO) initiative classifies an
individual as having CKD if abnormalities of kidney structure or function persist
for >3 months. KDIGO describes a classification of severity, defining numerous
stages of CKD based on glomerular filtration rate (GFR; either estimated [eGFR]
or measured [mGFR]) and the extent of albuminuria.
• The mechanisms initially involve adaptive changes to loss of nephrons that
eventually have maladaptive consequences. Clinical manifestations of
progression common to most renal diseases are decreased GFR, hypertension,
and proteinuria. Besides, common pathologic findings are glomerulosclerosis,
tubulointerstitial fibrosis, inflammation, tubular atrophy, and capillary loss.

6. Chronic Kidney Disease
(CKD)
Epidemiology Insight

7. According to DelveInsight’s analysis, non-dialysis
dependent patients are more as compared to
dialysis-dependent patients, in case of Chronic
Kidney Disease (CKD)
• The most prevalent cases of Chronic Kidney
Disease (CKD) were recorded in the United States.
• Among the European 5 countries, Germany had the
highest prevalent population of Chronic Kidney
Disease (CKD), followed by France and the United
Kingdom. On the other hand, Spain had the lowest
prevalent population of CKD in 2017.
Prevalent Cases of Chronic Kidney Disease (CKD) by Stage

8. Chronic Kidney Disease
(CKD)
Market Insight
11 Years
Forecast
7MM
Coverage
Epidemiology
Segmentation
Key Cross
Competition
Highly
Analyzed
Market
Drugs
Uptake

9. Lorem Ipsum is simply dummy text of
the printing and typesetting industry.
9
Market Size of Chronic Kidney Disease
in the 7MM has been estimated to be
Chronic Kidney Disease (CKD) Market
XX XX XX
US Germany France
XX
Italy
XX XX XX
Spain UK Japan
MARKET SHARE SEGMENTATION OF 7MM COUNTRIES IN 2030

10. Chronic Kidney Disease
(CKD)
Emerging Therapies

11. 11
Emerging Therapies
Daprodustat
Vadadustat
Roxadustat
Empagliflozin
Veverimer
Bardoxolone Methyl
Dapagliflozin
Companies Companies
Drugs Drugs
Ziltivekimab

12. Market Drivers & Barrier
Market Driver
Market Barrier
Advances and Future Research
Opportunities associated with CKD
Disease Multiplier
Threats associated with Comorbidities
Knowledge Gaps
Increasing Prevalence Early Detection and Precision
Medicine
Limited Patient Education

13. KOL Opinion Analysis
Rare Disease Segment has scarcity of data through published literature, with statistical analysis also having dearth of information.
DelveInsight surpasses this challenge through its extensive Primary Research, through its association with Key Opinion Leaders across the
Globe
R&D Assessment
KOLs include Research
Scientists, Clinical Trial
Investigators, Research Nurses,
General Practitioners, Medical
Consultants, as well as Specialty
Physicians
Epidemiology Assessment
KOLs include Epidemiologists, Company
Personnel, Disease Organizations’ Executives,
Medical Consultants, Consulting analysts, as
well as Specialty Physicians etc.
Market Assessment
KOLs include Financial Analysts,
Freelance Consultants, Company
Personnel, B Consulting analysts,
as well as Specialty Physicians
etc.

14. DelveInsight KOL Network
DelveInsight has an extensive KOL Network, from in-house experts to associated personnel, across all geographies, who provide accurate
and real time insights on the research needs of DelveInsight’s clients
Our Extensive Coverage of the
Healthcare Industry can be assessed
from our reach across the Global
Markets
Our External panel consists of our
associations with Key Opinion Leaders on
Project basis, where we recruit key personnel
related to the therapy area/disease area in
question to assess thoughts on the Industry
Trends
Our internal panel consists of Dr. BK
Agrawal and his associations of
Pharma Consultants, Medical
Doctors and Industry Leaders

15. Pricing & Reimbursement

16. Related Reports
DelveInsight’s, “Chronic Kidney Disease (CKD) – Pipeline Insight, 2020,” report provides comprehensive
insights about 50+ companies and 50+ pipeline drugs in Chronic Kidney Disease pipeline landscape. It
covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the
therapeutics assessment by product type, stage, route of administration, and molecule type. It further
highlights the inactive pipeline products in this space.
 Chronic Kidney Disease (CKD) – Pipeline Insight, 2020
 Chronic kidney disease (CKD)- Epidemiology Forecast to 2030
DelveInsight’s ‘Chronic kidney disease (CKD)- Epidemiology Forecast to 2030’ report delivers an in-
depth understanding of the disease, historical & forecasted epidemiology of Chronic kidney disease in the
United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

17. Contact Us
+91-11-45689769
+1(919)-321-6187
info@delveinsight.com Click Here Click Here
Click Here to visit our Report Store

18. Thank You